p53 Activators are a diverse group of chemicals that enhance the functional activity of p53, a critical tumor suppressor protein. Nutlin-3a, RITA, Cyclic Pifithrin-α, JNJ-26854165, and NSC 66811 are all molecules that interfere with the interaction between p53 and its negative regulators, MDM2 and MDMX. By preventing ubiquitination and proteasomal degradation of p53, Nutlin-3a allows for the accumulation and activation of p53 within the cell. Similarly, RITA binds directly to p53, protecting it from MDM2-mediated degradation. Cyclic Pifithrin-α and JNJ-26854165 inhibit the p53-MDM2 interaction, which leads to p53 stabilization, and NSC 66811 targets the p53-MDMX interaction, contributing to the enhanced activity of p53. Additionally, Prima-1, SCH 529074, CP-31398, and MIRA-1 are compounds that restore the active conformation and functionality of mutant p53, thereby reactivating its tumor suppressor roles. Piperlongumine exerts its effect by elevating ROS levels, which can trigger a p53-dependent cellular stress response.
Moreover, Tenovin-6 and Sirtinol enhance p53 activity by inhibiting the deacetylase activities of SIRT1 and SIRT2, resulting in increased p53 acetylation and subsequent activation. This modification is crucial for p53's role in the DNA damage response, leading to cell cycle arrest or apoptosis in damaged cells. The activation of p53 by these compounds is a significant event in maintaining the integrity of the genome and preventing the proliferation of potentially oncogenic cells. Collectively, these p53 Activators work through various pathways to ensure the proper function of p53, either by directly blocking its degradation, reactivating mutated forms, or by modulating post-translational modifications that areessential for its activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(–)-Nutlin-3 | 675576-98-4 | sc-222086 sc-222086A | 1 mg 5 mg | $122.00 $219.00 | 2 | |
A MDM2 antagonist that prevents the MDM2-mediated ubiquitination and subsequent degradation of p53, leading to the stabilization and activation of the p53 protein. | ||||||
Tenovin-6 | 1011557-82-6 | sc-224296 sc-224296A | 1 mg 5 mg | $272.00 $1214.00 | 9 | |
A small molecule that activates p53 by inhibiting the protein deacetylase activities of SIRT1 and SIRT2, resulting in increased acetylation and activation of p53. | ||||||
p53 Activator III, RITA | 213261-59-7 | sc-202753 sc-202753A sc-202753B sc-202753C | 1 mg 10 mg 100 mg 500 mg | $112.00 $273.00 $1564.00 $5205.00 | 9 | |
A small molecule that binds to p53, blocking its interaction with the E3 ubiquitin-protein ligase MDM2, which leads to p53 activation and accumulation in the cell. | ||||||
PRIMA-1 | 5608-24-2 | sc-200927 sc-200927A | 5 mg 25 mg | $102.00 $408.00 | 1 | |
A compound that restores the active conformation of mutant p53, leading to its reactivation and restoration of tumor suppressor functions. | ||||||
Piperlongumine | 20069-09-4 | sc-364128 | 10 mg | $107.00 | ||
A bioactive compound from the Piper longum plant; increases the levels of reactive oxygen species (ROS) within cells, which can enhance p53 activation as part of the cellular stress response. | ||||||
Pifithrin-α hydrobromide | 63208-82-2 | sc-45050 sc-45050A | 5 mg 25 mg | $120.00 $300.00 | 36 | |
A cyclic version of pifithrin-α that inhibits the interaction between p53 and its negative regulator MDM2, leading to increased p53 activity. | ||||||
JNJ 26854165 | 881202-45-5 | sc-364514 sc-364514A | 5 mg 25 mg | $171.00 $577.00 | ||
A small molecule that acts as an HDM2 (human MDM2) antagonist, leading to the stabilization and activation of p53. | ||||||
PAC 1 | 315183-21-2 | sc-203174 sc-203174A | 10 mg 50 mg | $132.00 $536.00 | 1 | |
A small molecule that modulates mutant p53 proteins to a conformation that resembles wild-type p53, resulting in p53 reactivation. | ||||||
Sirtinol | 410536-97-9 | sc-205976 sc-205976A | 1 mg 5 mg | $38.00 $113.00 | 14 | |
An inhibitor of the NAD-dependent deacetylase SIRT1, leading to increased acetylation and activation of p53 as part of the DNA damage response. | ||||||
THIQ | 312637-48-2 | sc-204343 sc-204343A | 1 mg 10 mg | $260.00 $1200.00 | 1 | |
A compound that disrupts the interaction between p53 and MDMX, another negative regulator of p53, leading to increased p53 activation. | ||||||